Author:
Chou Kuo-Chen,Wei Dong-Qing,Du Qi-Shi,Sirois Suzanne,Shen Hong-Bin,Zhong Wei-Zhu
Reference80 articles.
1. Adessi, C. and Soto, C. 2002, Converting a peptide into a drug: strategies to improve stability and bioavailability. Curr Med Chem, 9, 963–978.
2. Anand, K., Ziebuhr, J., Wadhwani, P., Mesters, J.R. and Hilgenfeld, R. 2003, Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs. Science, 300, 1763–1767.
3. Baurin, N. 2002, Etude et développement de techniques QSAR pour la recherche de molécules d'intérêts thérapeutique. Criblage virtuel et Analyse de chmiothèque, Université d'Orléans.
4. Benkirane, N., Guichard, G., Briand, J.P. and Muller, S. 1996, Exploration of requirements for peptidomimetic immune recognition. Antigenic and immunogenic properties of reduced pep-tide bond pseudopeptide analogues of a histone hexapeptide. J Biol Chem, 271, 33218–33224.
5. Cai, Y.D. and Chou, K.C. 1998, Artificial neural network model for HIV protease cleavage sites in proteins. Adv Eng Softw, 29, 119–128.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献